Cover Image
Market Research Report

Global Neurodegenerative Diseases Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

Published by QYResearch Product code 750048
Published Content info 123 Pages
Delivery time: 3-5 business days
Price
Back to Top
Global Neurodegenerative Diseases Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
Published: November 29, 2018 Content info: 123 Pages
Description

Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies. Neurodegenerative diseases are characterized by neuronal death within the brain and/or central nervous system (CNS), leading to progressive decline in functional neurological capacities. It has a devastating effect on quality of life and independence, often requiring full-time care during the later disease stages.

In 2018, the global Neurodegenerative Diseases market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Neurodegenerative Diseases.

This study researches the market size of Neurodegenerative Diseases, presents the global Neurodegenerative Diseases sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

This report focuses on the key data information of Neurodegenerative Diseases in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Neurodegenerative Diseases for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.

  • Novartis
  • Merck Serono
  • Teva Pharmaceutical
  • UCB
  • Pfizer
  • Biogen Idec
  • Bayer Schering Pharma AG
  • Boehringer Ingelheim
  • Addex Pharmaceutical
  • Amarin
  • AstraZeneca
  • Asubio Pharmaceutical
  • Bial
  • Alector
  • Yumanity Therapeutics
  • Eisai
  • H.Lundbeck A/S
  • Jiangsu Hansoh Pharmaceutical
  • Yangtze River Pharmaceutical Group
  • Chongqing Zein Pharmaceutical

Market Segment by Product Type

  • NMDA
  • SSRIs
  • Dopamine Inhibitors

Market Segment by Application

  • Parkinson's disease
  • Huntington disease
  • Amyotrophic Lateral Sclerosis
  • Alzheimer's disease

Market size split by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Neurodegenerative Diseases status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Neurodegenerative Diseases manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Neurodegenerative Diseases are as follows:

  • History Year: 2013-2018
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025
Table of Contents

Table of Contents

1. Report Overview

  • 1.1. Research Scope
  • 1.2. Major Manufacturers Covered in This Report
  • 1.3. Market Segment by Type
    • 1.3.1. Global Neurodegenerative Diseases Market Size Growth Rate by Type
    • 1.3.2. NMDA
    • 1.3.3. SSRIs
    • 1.3.4. Dopamine Inhibitors
  • 1.4. Market Segment by Application
    • 1.4.1. Global Neurodegenerative Diseases Market Share by Application (2018-2025)
    • 1.4.2. Parkinson's disease
    • 1.4.3. Huntington disease
    • 1.4.4. Amyotrophic Lateral Sclerosis
    • 1.4.5. Alzheimer's disease
  • 1.5. Study Objectives
  • 1.6. Years Considered

2. Global Growth Trends

  • 2.1. Global Neurodegenerative Diseases Market Size
    • 2.1.1. Global Neurodegenerative Diseases Revenue 2013-2025
    • 2.1.2. Global Neurodegenerative Diseases Sales 2013-2025
  • 2.2. Neurodegenerative Diseases Growth Rate by Regions
    • 2.2.1. Global Neurodegenerative Diseases Sales by Regions 2013-2018
    • 2.2.2. Global Neurodegenerative Diseases Revenue by Regions 2013-2018
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers

3. Market Share by Manufacturers

  • 3.1. Neurodegenerative Diseases Sales by Manufacturers
    • 3.1.1. Neurodegenerative Diseases Sales by Manufacturers 2013-2018
    • 3.1.2. Neurodegenerative Diseases Sales Market Share by Manufacturers 2013-2018
  • 3.2. Revenue by Manufacturers
    • 3.2.1. Neurodegenerative Diseases Revenue by Manufacturers (2013-2018)
    • 3.2.2. Neurodegenerative Diseases Revenue Share by Manufacturers (2013-2018)
    • 3.2.3. Global Neurodegenerative Diseases Market Concentration Ratio (CR5 and HHI)
  • 3.3. Neurodegenerative Diseases Price by Manufacturers
  • 3.4. Key Manufacturers Neurodegenerative Diseases Plants/Factories Distribution and Area Served
  • 3.5. Date of Key Manufacturers Enter into Neurodegenerative Diseases Market
  • 3.6. Key Manufacturers Neurodegenerative Diseases Product Offered
  • 3.7. Mergers & Acquisitions, Expansion Plans

4. Market Size by Type

  • 4.1. Sales and Revenue for Each Type
    • 4.1.1. NMDA Sales and Revenue (2013-2018)
    • 4.1.2. SSRIs Sales and Revenue (2013-2018)
    • 4.1.3. Dopamine Inhibitors Sales and Revenue (2013-2018)
  • 4.2. Global Neurodegenerative Diseases Sales Market Share by Type
  • 4.3. Global Neurodegenerative Diseases Revenue Market Share by Type
  • 4.4. Neurodegenerative Diseases Price by Type

5. Market Size by Application

  • 5.1. Overview
  • 5.2. Global Neurodegenerative Diseases Sales by Application

6. North America

  • 6.1. North America Neurodegenerative Diseases Breakdown Data by Company
  • 6.2. North America Neurodegenerative Diseases Breakdown Data by Type
  • 6.3. North America Neurodegenerative Diseases Breakdown Data by Application
  • 6.4. North America Neurodegenerative Diseases Breakdown Data by Countries
    • 6.4.1. North America Neurodegenerative Diseases Sales by Countries
    • 6.4.2. North America Neurodegenerative Diseases Revenue by Countries
    • 6.4.3. United States
    • 6.4.4. Canada
    • 6.4.5. Mexico

7. Europe

  • 7.1. Europe Neurodegenerative Diseases Breakdown Data by Company
  • 7.2. Europe Neurodegenerative Diseases Breakdown Data by Type
  • 7.3. Europe Neurodegenerative Diseases Breakdown Data by Application
  • 7.4. Europe Neurodegenerative Diseases Breakdown Data by Countries
    • 7.4.1. Europe Neurodegenerative Diseases Sales by Countries
    • 7.4.2. Europe Neurodegenerative Diseases Revenue by Countries
    • 7.4.3. Germany
    • 7.4.4. France
    • 7.4.5. UK
    • 7.4.6. Italy
    • 7.4.7. Russia

8. Asia Pacific

  • 8.1. Asia Pacific Neurodegenerative Diseases Breakdown Data by Company
  • 8.2. Asia Pacific Neurodegenerative Diseases Breakdown Data by Type
  • 8.3. Asia Pacific Neurodegenerative Diseases Breakdown Data by Application
  • 8.4. Asia Pacific Neurodegenerative Diseases Breakdown Data by Countries
    • 8.4.1. Asia Pacific Neurodegenerative Diseases Sales by Countries
    • 8.4.2. Asia Pacific Neurodegenerative Diseases Revenue by Countries
    • 8.4.3. China
    • 8.4.4. Japan
    • 8.4.5. Korea
    • 8.4.6. India
    • 8.4.7. Australia
    • 8.4.8. Indonesia
    • 8.4.9. Malaysia
    • 8.4.10. Philippines
    • 8.4.11. Thailand
    • 8.4.12. Vietnam

9. Central & South America

  • 9.1. Central & South America Neurodegenerative Diseases Breakdown Data by Company
  • 9.2. Central & South America Neurodegenerative Diseases Breakdown Data by Type
  • 9.3. Central & South America Neurodegenerative Diseases Breakdown Data by Application
  • 9.4. Central & South America Neurodegenerative Diseases Breakdown Data by Countries
    • 9.4.1. Central & South America Neurodegenerative Diseases Sales by Countries
    • 9.4.2. Central & South America Neurodegenerative Diseases Revenue by Countries
    • 9.4.3. Brazil

10. Middle East and Africa

  • 10.1. Middle East and Africa Neurodegenerative Diseases Breakdown Data by Type
  • 10.2. Middle East and Africa Neurodegenerative Diseases Breakdown Data by Application
  • 10.3. Middle East and Africa Neurodegenerative Diseases Breakdown Data by Countries
    • 10.3.1. Middle East and Africa Neurodegenerative Diseases Sales by Countries
    • 10.3.2. Middle East and Africa Neurodegenerative Diseases Revenue by Countries
    • 10.3.3. GCC Countries
    • 10.3.4. Egypt
    • 10.3.5. South Africa

11. Company Profiles

  • 11.1. Novartis
    • 11.1.1. Novartis Company Details
    • 11.1.2. Company Description and Business Overview
    • 11.1.3. Sales, Revenue and Market Share of Neurodegenerative Diseases
    • 11.1.4. Neurodegenerative Diseases Product Introduction
    • 11.1.5. Novartis Recent Development
  • 11.2. Merck Serono
    • 11.2.1. Merck Serono Company Details
    • 11.2.2. Company Description and Business Overview
    • 11.2.3. Sales, Revenue and Market Share of Neurodegenerative Diseases
    • 11.2.4. Neurodegenerative Diseases Product Introduction
    • 11.2.5. Merck Serono Recent Development
  • 11.3. Teva Pharmaceutical
    • 11.3.1. Teva Pharmaceutical Company Details
    • 11.3.2. Company Description and Business Overview
    • 11.3.3. Sales, Revenue and Market Share of Neurodegenerative Diseases
    • 11.3.4. Neurodegenerative Diseases Product Introduction
    • 11.3.5. Teva Pharmaceutical Recent Development
  • 11.4. UCB
    • 11.4.1. UCB Company Details
    • 11.4.2. Company Description and Business Overview
    • 11.4.3. Sales, Revenue and Market Share of Neurodegenerative Diseases
    • 11.4.4. Neurodegenerative Diseases Product Introduction
    • 11.4.5. UCB Recent Development
  • 11.5. Pfizer
    • 11.5.1. Pfizer Company Details
    • 11.5.2. Company Description and Business Overview
    • 11.5.3. Sales, Revenue and Market Share of Neurodegenerative Diseases
    • 11.5.4. Neurodegenerative Diseases Product Introduction
    • 11.5.5. Pfizer Recent Development
  • 11.6. Biogen Idec
    • 11.6.1. Biogen Idec Company Details
    • 11.6.2. Company Description and Business Overview
    • 11.6.3. Sales, Revenue and Market Share of Neurodegenerative Diseases
    • 11.6.4. Neurodegenerative Diseases Product Introduction
    • 11.6.5. Biogen Idec Recent Development
  • 11.7. Bayer Schering Pharma AG
    • 11.7.1. Bayer Schering Pharma AG Company Details
    • 11.7.2. Company Description and Business Overview
    • 11.7.3. Sales, Revenue and Market Share of Neurodegenerative Diseases
    • 11.7.4. Neurodegenerative Diseases Product Introduction
    • 11.7.5. Bayer Schering Pharma AG Recent Development
  • 11.8. Boehringer Ingelheim
    • 11.8.1. Boehringer Ingelheim Company Details
    • 11.8.2. Company Description and Business Overview
    • 11.8.3. Sales, Revenue and Market Share of Neurodegenerative Diseases
    • 11.8.4. Neurodegenerative Diseases Product Introduction
    • 11.8.5. Boehringer Ingelheim Recent Development
  • 11.9. Addex Pharmaceutical
    • 11.9.1. Addex Pharmaceutical Company Details
    • 11.9.2. Company Description and Business Overview
    • 11.9.3. Sales, Revenue and Market Share of Neurodegenerative Diseases
    • 11.9.4. Neurodegenerative Diseases Product Introduction
    • 11.9.5. Addex Pharmaceutical Recent Development
  • 11.10. Amarin
    • 11.10.1. Amarin Company Details
    • 11.10.2. Company Description and Business Overview
    • 11.10.3. Sales, Revenue and Market Share of Neurodegenerative Diseases
    • 11.10.4. Neurodegenerative Diseases Product Introduction
    • 11.10.5. Amarin Recent Development
  • 11.11. AstraZeneca
  • 11.12. Asubio Pharmaceutical
  • 11.13. Bial
  • 11.14. Alector
  • 11.15. Yumanity Therapeutics
  • 11.16. Eisai
  • 11.17. H.Lundbeck A/S
  • 11.18. Jiangsu Hansoh Pharmaceutical
  • 11.19. Yangtze River Pharmaceutical Group
  • 11.20. Chongqing Zein Pharmaceutical

12. Value Chain and Sales Channels Analysis

  • 12.1. Value Chain Analysis
  • 12.2. Sales Channels Analysis
    • 12.2.1. Neurodegenerative Diseases Sales Channels
    • 12.2.2. Neurodegenerative Diseases Distributors
  • 12.3. Neurodegenerative Diseases Customers

13. Market Forecast

  • 13.1. Global Neurodegenerative Diseases Sales and Revenue Forecast 2018-2025
  • 13.2. Global Neurodegenerative Diseases Sales Forecast by Type
  • 13.3. Global Neurodegenerative Diseases Sales Forecast by Application
  • 13.4. Neurodegenerative Diseases Forecast by Regions
    • 13.4.1. Global Neurodegenerative Diseases Sales Forecast by Regions 2018-2025
    • 13.4.2. Global Neurodegenerative Diseases Revenue Forecast by Regions 2018-2025
  • 13.5. North America Market Forecast
    • 13.5.1. North America Neurodegenerative Diseases Forecast by Countries 2018-2025
    • 13.5.2. United States
    • 13.5.3. Canada
    • 13.5.4. Mexico
  • 13.6. Europe Market Forecast
    • 13.6.1. Europe Neurodegenerative Diseases Forecast by Countries 2018-2025
    • 13.6.2. Germany
    • 13.6.3. France
    • 13.6.4. UK
    • 13.6.5. Italy
    • 13.6.6. Russia
  • 13.7. Asia Pacific Market Forecast
    • 13.7.1. Asia Pacific Neurodegenerative Diseases Sales Forecast by Countries 2018-2025
    • 13.7.2. China
    • 13.7.3. Japan
    • 13.7.4. Korea
    • 13.7.5. India
    • 13.7.6. Australia
    • 13.7.7. Indonesia
    • 13.7.8. Thailand
    • 13.7.9. Malaysia
    • 13.7.10. Philippines
    • 13.7.11. Vietnam
  • 13.8. Central & South America Market Forecast
    • 13.8.1. Central & South America Neurodegenerative Diseases Sales Forecast by Countries 2018-2025
    • 13.8.2. Brazil
  • 13.9. Middle East and Africa Market Forecast
    • 13.9.1. Middle East and Africa Neurodegenerative Diseases Sales Forecast by Countries 2018-2025
    • 13.9.2. GCC Countries
    • 13.9.3. Egypt
    • 13.9.4. South Africa

14. Research Findings and Conclusion

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
      • 15.1.1.1. Research Programs/Design
      • 15.1.1.2. Market Size Estimation
      • 15.1.1.3. Market Breakdown and Data Triangulation
    • 15.1.2. Data Source
      • 15.1.2.1. Secondary Sources
      • 13.1.2.2. Primary Sources
  • 15.2. Author Details
  • 15.3. Disclaimer

List of Tables and Figures

  • Figure Neurodegenerative Diseases Product Picture
  • Table Neurodegenerative Diseases Key Market Segments
  • Table Major Manufacturers Neurodegenerative Diseases Covered in This Report
  • Table Global Neurodegenerative Diseases Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
  • Figure Global Neurodegenerative Diseases Sales Market Shar by Type 2013-2025
  • Figure NMDA Figures
  • Table Major Manufacturers of NMDA
  • Figure SSRIs Figures
  • Table Major Manufacturers of SSRIs
  • Figure Dopamine Inhibitors Figures
  • Table Major Manufacturers of Dopamine Inhibitors
  • Table Global Neurodegenerative Diseases Market Share by Application 2018-2025 (K Units)
  • Figure Parkinson's disease Use Case
  • Figure Huntington disease Use Case
  • Figure Amyotrophic Lateral Sclerosis Use Case
  • Figure Alzheimer's disease Use Case
  • Figure Neurodegenerative Diseases Report Years Considered
  • Figure Global Neurodegenerative Diseases Market Size 2013-2025 (Million US$)
  • Figure Global Neurodegenerative Diseases Sales 2013-2018 (K Units)
  • Table Global Neurodegenerative Diseases Market Size by Regions 2013-2018 (K Units) & (Million US$)
  • Table Global Neurodegenerative Diseases Sales by Regions 2013-2018 (K Units)
  • Table Global Neurodegenerative Diseases Sales Market Share by Regions 2013-2018
  • Figure Global Neurodegenerative Diseases Sales Market Share by Regions 2013-2018
  • Figure Global Neurodegenerative Diseases Sales Market Share by Regions in 2018
  • Table Global Neurodegenerative Diseases Revenue by Regions 2013-2018 (Million US$)
  • Table Global Neurodegenerative Diseases Revenue Market Share by Regions 2013-2018
  • Figure Global Neurodegenerative Diseases Revenue Market Share by Regions 2013-2018
  • Figure Global Neurodegenerative Diseases Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global Neurodegenerative Diseases Sales by Manufacturers (2013-2018) (K Units)
  • Table Global Neurodegenerative Diseases Sales Share by Manufacturers (2013-2018)
  • Figure Global Neurodegenerative Diseases Sales Share by Manufacturers in 2018
  • Table Neurodegenerative Diseases Revenue by Manufacturers (2013-2018) (Million USD)
  • Table Neurodegenerative Diseases Revenue Share by Manufacturers (2013-2018)
  • Figure Neurodegenerative Diseases Value Share by Manufacturers in 2018
  • Table Global Neurodegenerative Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Neurodegenerative Diseases Price (2013-2018) (USD/Unit)
  • Table Key Manufacturers Neurodegenerative Diseases Plants/Factories Distribution
  • Table Key Manufacturers Neurodegenerative Diseases Area Served
  • Table Date of Key Manufacturers Enter into Neurodegenerative Diseases Market
  • Table Key Manufacturers Neurodegenerative Diseases Product Type
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global NMDA Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global SSRIs Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Dopamine Inhibitors Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Neurodegenerative Diseases Sales by Type (2013-2018) (K Units)
  • Table Global Neurodegenerative Diseases Sales Share by Type (2013-2018)
  • Figure Global Neurodegenerative Diseases Sales Market Share by Type (2013-2018)
  • Figure Global Neurodegenerative Diseases Sales Market Share by Type in 2017
  • Table Global Neurodegenerative Diseases Revenue by Type (2013-2018) (Million US$)
  • Table Global Neurodegenerative Diseases Revenue Share by Type (2013-2018)
  • Figure Global Neurodegenerative Diseases Revenue Market Share by Type (2013-2018)
  • Figure Global Neurodegenerative Diseases Revenue Market Share by Type in 2017
  • Table Neurodegenerative Diseases Price by Type 2013-2018 (USD/Unit)
  • Table Global Neurodegenerative Diseases Sales by Application (2013-2018) (K Units)
  • Table Global Neurodegenerative Diseases Sales Share by Application (2013-2018)
  • Figure Global Sales Neurodegenerative Diseases Market Share by Application (2013-2018)
  • Figure Global Sales Neurodegenerative Diseases Market Share by Application in 2017
  • Figure North America Neurodegenerative Diseases Sales Growth Rate 2013-2018 (K Units)
  • Figure North America Neurodegenerative Diseases Revenue Growth Rate 2013-2018 (Million US$)
  • Table North America Neurodegenerative Diseases Sales by Company (2013-2018) (K Units)
  • Table North America Neurodegenerative Diseases Sales Market Share by Company (2013-2018)
  • Figure North America Neurodegenerative Diseases Sales Market Share by Company in 2018
  • Table North America Neurodegenerative Diseases Sales by Type (2013-2018) (K Units)
  • Table North America Neurodegenerative Diseases Sales Market Share by Type (2013-2018)
  • Figure North America Neurodegenerative Diseases Market Share by Type in 2018
  • Table North America Neurodegenerative Diseases Sales by Application (2013-2018) (K Units)
  • Table North America Neurodegenerative Diseases Sales Market Share by Application (2013-2018)
  • Figure North America Neurodegenerative Diseases Market Share by Application in 2018
  • Table North America Neurodegenerative Diseases Sales by Countries (2013-2018) (K Units)
  • Table North America Neurodegenerative Diseases Sales Market Share by Countries (2013-2018)
  • Figure 2017 North America Neurodegenerative Diseases Sales Market Share by Countries
  • Table North America Neurodegenerative Diseases Revenue by Countries (2013-2018) (Million US$)
  • Table North America Neurodegenerative Diseases Revenue Market Share by Countries (2013-2018)
  • Figure 2017 North America Neurodegenerative Diseases Revenue Market Share by Countries
  • Figure United States Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Canada Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Mexico Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Europe Neurodegenerative Diseases Sales Growth Rate 2013-2018 (K Units)
  • Figure Europe Neurodegenerative Diseases Revenue Growth Rate 2013-2018 (Million US$)
  • Table Europe Neurodegenerative Diseases Sales by Company (2013-2018) (K Units)
  • Table Europe Neurodegenerative Diseases Sales Market Share by Company (2013-2018)
  • Figure Europe Neurodegenerative Diseases Sales Market Share by Company in 2018
  • Table Europe Neurodegenerative Diseases Sales by Type (2013-2018) (K Units)
  • Table Europe Neurodegenerative Diseases Sales Market Share by Type (2013-2018)
  • Figure 2017 Europe Neurodegenerative Diseases Market Share by Type
  • Table Europe Neurodegenerative Diseases Sales by Application (2013-2018) (K Units)
  • Table Europe Neurodegenerative Diseases Sales Market Share by Application (2013-2018)
  • Figure 2017 Europe Neurodegenerative Diseases Market Share by Application
  • Table Europe Neurodegenerative Diseases Sales by Countries (2013-2018) (K Units)
  • Table Europe Neurodegenerative Diseases Sales Market Share by Countries (2013-2018)
  • Figure 2017 Europe Neurodegenerative Diseases Sales Market Share by Countries
  • Table Europe Neurodegenerative Diseases Revenue by Countries (2013-2018) (Million US$)
  • Table Europe Neurodegenerative Diseases Revenue Market Share by Countries (2013-2018)
  • Figure Europe Neurodegenerative Diseases Revenue Market Share by Countries in 2018
  • Figure Germany Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure France Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure UK Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Italy Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Russia Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Asia Pacific Neurodegenerative Diseases Sales Growth Rate 2013-2018 (K Units)
  • Figure Asia Pacific Neurodegenerative Diseases Revenue Growth Rate 2013-2018 (Million US$)
  • Table Asia Pacific Neurodegenerative Diseases Sales by Company (2013-2018) (K Units)
  • Table Asia Pacific Neurodegenerative Diseases Sales Market Share by Company (2013-2018)
  • Figure Asia Pacific Neurodegenerative Diseases Sales Market Share by Company in 2018
  • Table Asia Pacific Neurodegenerative Diseases Sales by Type (2013-2018) (K Units)
  • Table Asia Pacific Neurodegenerative Diseases Sales Market Share by Type (2013-2018)
  • Figure Asia Pacific Neurodegenerative Diseases Market Share by Type in 2018
  • Table Asia Pacific Neurodegenerative Diseases Sales by Application (2013-2018) (K Units)
  • Table Asia Pacific Neurodegenerative Diseases Sales Market Share by Application (2013-2018)
  • Figure Asia Pacific Neurodegenerative Diseases Market Share by Application in 2018
  • Table Asia Pacific Neurodegenerative Diseases Sales by Countries (2013-2018) (K Units)
  • Table Asia Pacific Neurodegenerative Diseases Sales Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Neurodegenerative Diseases Sales Market Share by Countries
  • Table Asia Pacific Neurodegenerative Diseases Revenue by Countries (2013-2018) (Million US$)
  • Table Asia Pacific Neurodegenerative Diseases Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Neurodegenerative Diseases Revenue Market Share by Countries
  • Figure China Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure China Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Japan Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Japan Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Korea Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Korea Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (Million US$)
  • Figure India Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure India Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Australia Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Australia Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Indonesia Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Indonesia Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Malaysia Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Malaysia Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Philippines Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Philippines Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Thailand Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Thailand Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Vietnam Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Vietnam Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Central & South America Neurodegenerative Diseases Sales Growth Rate 2013-2018 (K Units)
  • Figure Central & South America Neurodegenerative Diseases Revenue Growth Rate 2013-2018 (Million US$)
  • Table Central & South America Neurodegenerative Diseases Sales by Company (2013-2018) (K Units)
  • Table Central & South America Neurodegenerative Diseases Sales Market Share by Company (2013-2018)
  • Figure Central & South America Neurodegenerative Diseases Sales Market Share by Company in 2018
  • Table Central & South America Neurodegenerative Diseases Sales by Type (2013-2018) (K Units)
  • Table Central & South America Neurodegenerative Diseases Sales Market Share by Type (2013-2018)
  • Figure Central & South America Neurodegenerative Diseases Market Share by Type in 2018
  • Table Central & South America Neurodegenerative Diseases Sales by Application (2013-2018) (K Units)
  • Table Central & South America Neurodegenerative Diseases Sales Market Share by Application (2013-2018)
  • Figure Central & South America Neurodegenerative Diseases Market Share by Application in 2018
  • Table Central & South America Neurodegenerative Diseases Sales by Countries (2013-2018) (K Units)
  • Table Central & South America Neurodegenerative Diseases Sales Market Share by Countries (2013-2018)
  • Figure Central & South America Neurodegenerative Diseases Sales Market Share by Countries in 2018
  • Table Central & South America Neurodegenerative Diseases Revenue by Countries (2013-2018) (Million US$)
  • Table Central & South America Neurodegenerative Diseases Revenue Market Share by Countries (2013-2018)
  • Figure Central & South America Neurodegenerative Diseases Revenue Market Share by Countries in 2018
  • Figure Brazil Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Brazil Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (K Units)
  • Figure Middle East and Africa Neurodegenerative Diseases Sales Growth Rate 2013-2018 (K Units)
  • Figure Middle East and Africa Neurodegenerative Diseases Revenue Growth Rate 2013-2018 (Million US$)
  • Table Middle East and Africa Neurodegenerative Diseases Sales by Type (2013-2018) (K Units)
  • Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Type (2013-2018)
  • Figure 2017 Middle East and Africa Neurodegenerative Diseases Market Share by Type
  • Table Middle East and Africa Neurodegenerative Diseases Sales by Application (2013-2018) (K Units)
  • Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Application (2013-2018)
  • Figure 2017 Middle East and Africa Neurodegenerative Diseases Market Share by Application
  • Table Middle East and Africa Neurodegenerative Diseases Sales by Countries (2013-2018) (K Units)
  • Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries
  • Table Middle East and Africa Neurodegenerative Diseases Revenue by Countries (2013-2018) (Million US$)
  • Table Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries
  • Figure GCC Countries Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure GCC Countries Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (K Units)
  • Figure Egypt Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure Egypt Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (K Units)
  • Figure South Africa Neurodegenerative Diseases Sales Growth Rate (2013-2018) (K Units)
  • Figure South Africa Neurodegenerative Diseases Revenue Growth Rate (2013-2018) (K Units)
  • Table Novartis Company Details
  • Table Novartis Description and Business Overview
  • Table Novartis Neurodegenerative Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Novartis Neurodegenerative Diseases Sales Growth Rate (2013-2018)
  • Table Novartis Neurodegenerative Diseases Sales Market Share in Global Market
  • Table Novartis Recent Development
  • Table Merck Serono Company Details
  • Table Merck Serono Description and Business Overview
  • Table Merck Serono Neurodegenerative Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Merck Serono Neurodegenerative Diseases Sales Growth Rate (2013-2018)
  • Table Merck Serono Neurodegenerative Diseases Sales Market Share in Global Market
  • Table Merck Serono Recent Development
  • Table Teva Pharmaceutical Company Details
  • Table Teva Pharmaceutical Description and Business Overview
  • Table Teva Pharmaceutical Neurodegenerative Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Teva Pharmaceutical Neurodegenerative Diseases Sales Growth Rate (2013-2018)
  • Table Teva Pharmaceutical Neurodegenerative Diseases Sales Market Share in Global Market
  • Table Teva Pharmaceutical Recent Development
  • Table UCB Company Details
  • Table UCB Description and Business Overview
  • Table UCB Neurodegenerative Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table UCB Neurodegenerative Diseases Sales Growth Rate (2013-2018)
  • Table UCB Neurodegenerative Diseases Sales Market Share in Global Market
  • Table UCB Recent Development
  • Table Pfizer Company Details
  • Table Pfizer Description and Business Overview
  • Table Pfizer Neurodegenerative Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Pfizer Neurodegenerative Diseases Sales Growth Rate (2013-2018)
  • Table Pfizer Neurodegenerative Diseases Sales Market Share in Global Market
  • Table Pfizer Recent Development
  • Table Biogen Idec Company Details
  • Table Biogen Idec Description and Business Overview
  • Table Biogen Idec Neurodegenerative Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Biogen Idec Neurodegenerative Diseases Sales Growth Rate (2013-2018)
  • Table Biogen Idec Neurodegenerative Diseases Sales Market Share in Global Market
  • Table Biogen Idec Recent Development
  • Table Bayer Schering Pharma AG Company Details
  • Table Bayer Schering Pharma AG Description and Business Overview
  • Table Bayer Schering Pharma AG Neurodegenerative Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Bayer Schering Pharma AG Neurodegenerative Diseases Sales Growth Rate (2013-2018)
  • Table Bayer Schering Pharma AG Neurodegenerative Diseases Sales Market Share in Global Market
  • Table Bayer Schering Pharma AG Recent Development
  • Table Boehringer Ingelheim Company Details
  • Table Boehringer Ingelheim Description and Business Overview
  • Table Boehringer Ingelheim Neurodegenerative Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Boehringer Ingelheim Neurodegenerative Diseases Sales Growth Rate (2013-2018)
  • Table Boehringer Ingelheim Neurodegenerative Diseases Sales Market Share in Global Market
  • Table Boehringer Ingelheim Recent Development
  • Table Addex Pharmaceutical Company Details
  • Table Addex Pharmaceutical Description and Business Overview
  • Table Addex Pharmaceutical Neurodegenerative Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Addex Pharmaceutical Neurodegenerative Diseases Sales Growth Rate (2013-2018)
  • Table Addex Pharmaceutical Neurodegenerative Diseases Sales Market Share in Global Market
  • Table Addex Pharmaceutical Recent Development
  • Table Amarin Company Details
  • Table Amarin Description and Business Overview
  • Table Amarin Neurodegenerative Diseases Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Amarin Neurodegenerative Diseases Sales Growth Rate (2013-2018)
  • Table Amarin Neurodegenerative Diseases Sales Market Share in Global Market
  • Table Amarin Recent Development
  • Table AstraZeneca Company Details
  • Table Asubio Pharmaceutical Company Details
  • Table Bial Company Details
  • Table Alector Company Details
  • Table Yumanity Therapeutics Company Details
  • Table Eisai Company Details
  • Table H.Lundbeck A/S Company Details
  • Table Jiangsu Hansoh Pharmaceutical Company Details
  • Table Yangtze River Pharmaceutical Group Company Details
  • Table Chongqing Zein Pharmaceutical Company Details
  • Figure Neurodegenerative Diseases Value Chain
  • Table Neurodegenerative Diseases Distributors List
  • Table Neurodegenerative Diseases Customers List
  • Table Global Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units) & (Million US$)
  • Figure Global Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure Global Neurodegenerative Diseases Revenue Forecast 2018-2025 (Million US$)
  • Table Global Neurodegenerative Diseases Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global Neurodegenerative Diseases Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global Neurodegenerative Diseases Sales Market Share Forecast by Type 2018-2025
  • Table Global Neurodegenerative Diseases Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global Neurodegenerative Diseases Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global Neurodegenerative Diseases Sales Market Share Forecast by Application 2018-2025
  • Table Global Neurodegenerative Diseases Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global Neurodegenerative Diseases Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global Neurodegenerative Diseases Sales Market Share Forecast by Regions 2018-2025
  • Table Global Neurodegenerative Diseases Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Neurodegenerative Diseases Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Neurodegenerative Diseases Revenue Market Share Forecast by Regions 2018-2025
  • Table North America Neurodegenerative Diseases Sales Forecast by Countries 2018-2025 (K Units)
  • Table North America Neurodegenerative Diseases Sales Market Share Forecast by Countries 2018-2025
  • Table North America Neurodegenerative Diseases Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table North America Neurodegenerative Diseases Revenue Market Share Forecast by Countries 2018-2025
  • Figure United States Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure Canada Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure MexicoNeurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Table Europe Neurodegenerative Diseases Sales Forecast by Countries 2018-2025 (K Units)
  • Table Europe Neurodegenerative Diseases Sales Market Share Forecast by Countries 2018-2025
  • Table Europe Neurodegenerative Diseases Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Europe Neurodegenerative Diseases Revenue Market Share Forecast by Countries 2018-2025
  • Figure Germany Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure France Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure UK Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure Italy Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure Russia Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Table Asia Pacific Neurodegenerative Diseases Sales Forecast by Countries 2018-2025 (K Units)
  • Table Asia Pacific Neurodegenerative Diseases Sales Market Share Forecast by Countries 2018-2025
  • Table Asia Pacific Neurodegenerative Diseases Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Asia Pacific Neurodegenerative Diseases Revenue Market Share Forecast by Countries 2018-2025
  • Figure China Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure Japan Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure Korea Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure India Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure Australia Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure Indonesia Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure Thailand Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure Malaysia Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure Philippines Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Figure Vietnam Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Table Central & South America Neurodegenerative Diseases Sales Forecast by Countries 2018-2025 (K Units)
  • Table Central & South America Neurodegenerative Diseases Sales Market Share Forecast by Countries 2018-2025
  • Table Central & South America Neurodegenerative Diseases Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Central & South America Neurodegenerative Diseases Revenue Market Share Forecast by Countries 2018-2025
  • Figure Brazil Neurodegenerative Diseases Sales Forecast 2018-2025 (K Units)
  • Table Middle East and Africa Neurodegenerative Diseases Sales Forecast by Regions 2018-2025 (K Units)
  • Table Middle East and Africa Neurodegenerative Diseases Sales Market Share Forecast by Regions 2018-2025
  • Table Middle East and Africa Neurodegenerative Diseases Revenue Forecast by Regions 2018-2025 (Million US$)
  • Table Middle East and Africa Neurodegenerative Diseases Revenue Market Share Forecast by Regions 2018-2025
  • Figure GCC Countries Neurodegenerative Diseases Sales Growth Rate (2016-2025) (K Units)
  • Figure Egypt Neurodegenerative Diseases Sales Growth Rate (2016-2025) (K Units)
  • Figure South Africa Neurodegenerative Diseases Sales Growth Rate (2016-2025) (K Units)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top